BAM
CRL icon

Bell Asset Management’s Charles River Laboratories CRL Stock Holding History

Bell Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,171
Closed -$5.75M – 65
2024
Q3 		$5.75M Sell
29,171
-15,646
-35% -$3.25M 1.05% 48
2024
Q2 		$9.26M Buy
44,817
+6,145
+16% +$1.39M 1.3% 26
2024
Q1 		$10.5M Sell
38,672
-4,767
-11% -$1.14M 1.54% 25
2023
Q4 		$10.3M Sell
43,439
-6,868
-14% -$1.35M 1.57% 19
2023
Q3 		$9.86M Buy
50,307
+4,403
+10% +$904K 1.62% 19
2023
Q2 		$9.65M Buy
45,904
+4,296
+10% +$855K 1.65% 20
2023
Q1 		$8.4M Sell
41,608
-248
-0.6% -$56.2K 1.53% 27
2022
Q4 		$9.12M Sell
41,856
-391
-0.9% -$85.4K 1.71% 24
2022
Q3 		$8.31M Buy
42,247
+2,605
+7% +$562K 1.69% 29
2022
Q2 		$8.48M Buy
39,642
+8,349
+27% +$2.04M 1.67% 21
2022
Q1 		$8.89M Buy
31,293
+6,885
+28% +$2.12M 1.53% 25
2021
Q4 		$9.2M Buy
24,408
+7,983
+49% +$3.1M 1.48% 32
2021
Q3 		$6.78M Sell
16,425
-868
-5% -$360K 1.16% 46
2021
Q2 		$6.4M Sell
17,293
-91
-0.5% -$30.4K 1.25% 38
2021
Q1 		$5.04M Sell
17,384
-4,047
-19% -$1.12M 1.08% 52
2020
Q4 		$5.36M Buy
21,431
+1,104
+5% +$263K 1.17% 48
2020
Q3 		$4.6M Sell
20,327
-4,289
-17% -$890K 1.15% 49
2020
Q2 		$4.29M Sell
24,616
-17,197
-41% -$2.74M 1.16% 50
2020
Q1 		$5.28M Buy
41,813
+8,749
+26% +$1.31M 1.64% 25
2019
Q4 		$5.05M Buy
+33,064
New +$4.58M 1.3% 39

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Bell Asset Management's CRL Position: Q4 2024 in Review

Bell Asset Management sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 29,171 shares — an estimated $5.75M sold.

Bell Asset Management first reported a position in CRL in Q4 2019 and held it in 20 quarters. The position peaked at $10.5M in Q1 2024. 636 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Bell Asset Management reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Bell Asset Management sold 29,171 Charles River Laboratories shares in Q4 2024, an estimated $5.75M.
  • Bell Asset Management first reported a position in Charles River Laboratories in Q4 2019 and held it in 20 quarters.
  • Bell Asset Management's Charles River Laboratories position peaked at $10.5M in Q1 2024.
  • 636 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Bell Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.